Go to Page # Page of 3

Atosiban

 Atosiban
  9th-Oct-2018
Description: Atosiban is a nonapeptide, desamino-oxytocin analogue, and a competitive vasopressin/oxytocin receptor antagonist (VOTra). Atosiban is indicated to delay imminent pre-term birth in pregnant adult women. Atosiban is useful in improving the pregnancy outcome of in vitro fertilization-embryo transfer (IVF-ET) in patients with repeated implantation failure (RIF). The pregnancy rate improved from zero to 43.7%.
Important Tags: Atosiban
Views: 1340
Domain: Business
Category: Companies

Recent Presentations

Data Integrity in a Changing Environment

Lilly unites with discovery to create medicines that make life better for people around the world. The presentation covers what is data integrity, and why data integrity is importa

...
10 December, 2018
...
07 December, 2018
...
06 December, 2018